Filed: 2/14/2024ACC: 0001315863-24-000250
📋 What this filing means
TWO SEAS CAPITAL LP filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $409.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$409.54M
Total AUM (reported)
58.42M
Total Shares
Allocation by class
ORD$210.89M51.5%
SHS$95.55M23.3%
COM$76.52M18.7%
NOTE 4.000%11/1$10.04M2.5%
CL A$9.26M2.3%
COM NEW$7.18M1.8%
*W EXP 06/30/205$92.3K0.0%
Portfolio Concentration
Top 3$329.42M80.4%
4–10$79.22M19.3%
11–25$894.3K0.2%
Top 3 weight
80.4%
Top 10 weight
99.8%
Voting Authority Distribution
Total shares with voting rights: 58.42M
Sole
Full voting authority
58.42M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
INDIVIOR PLC
SOLEShares13.81M
TypeSH
Market value$210.89M
51.50%
Sole
13.81M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares8.51M
TypeSH
Market value$95.55M
23.33%
Sole
8.51M
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares7.69M
TypeSH
Market value$22.98M
5.61%
Sole
7.69M
Shared
0.00
None
0.00
ARBUTUS BIOPHARMA CORP
SOLEShares9.04M
TypeSH
Market value$22.60M
5.52%
Sole
9.04M
Shared
0.00
None
0.00
3M CO
SOLEShares144.79K
TypeSH
Market value$15.83M
3.86%
Sole
144.79K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares285.35K
TypeSH
Market value$12.02M
2.94%
Sole
285.35K
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares17.27M
TypePRN
Market value$10.04M
2.45%
Sole
17.27M
Shared
0.00
None
0.00
META PLATFORMS INC
SOLEShares26.18K
TypeSH
Market value$9.26M
2.26%
Sole
26.18K
Shared
0.00
None
0.00
ODYSSEY MARINE EXPL INC
SOLEShares1.37M
TypeSH
Market value$6.38M
1.56%
Sole
1.37M
Shared
0.00
None
0.00
SONOS INC
SOLEShares179.73K
TypeSH
Market value$3.08M
0.75%
Sole
179.73K
Shared
0.00
None
0.00
HERTZ GLOBAL HLDGS INC
SOLEShares77.19K
TypeSH
Market value$802.0K
0.20%
Sole
77.19K
Shared
0.00
None
0.00
HERTZ GLOBAL HLDGS INC
SOLEShares16.84K
TypeSH
Market value$92.3K
0.02%
Sole
16.84K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INDIVIOR PLCSOLE | ORD | 13.81M | SH | $210.89M 51.50% | 13.81M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 8.51M | SH | $95.55M 23.33% | 8.51M | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | COM | 7.69M | SH | $22.98M 5.61% | 7.69M | 0.00 | 0.00 |
ARBUTUS BIOPHARMA CORPSOLE | COM | 9.04M | SH | $22.60M 5.52% | 9.04M | 0.00 | 0.00 |
3M COSOLE | COM | 144.79K | SH | $15.83M 3.86% | 144.79K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 285.35K | SH | $12.02M 2.94% | 285.35K | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | NOTE 4.000%11/1 | 17.27M | PRN | $10.04M 2.45% | 17.27M | 0.00 | 0.00 |
META PLATFORMS INCSOLE | CL A | 26.18K | SH | $9.26M 2.26% | 26.18K | 0.00 | 0.00 |
ODYSSEY MARINE EXPL INCSOLE | COM NEW | 1.37M | SH | $6.38M 1.56% | 1.37M | 0.00 | 0.00 |
SONOS INCSOLE | COM | 179.73K | SH | $3.08M 0.75% | 179.73K | 0.00 | 0.00 |
HERTZ GLOBAL HLDGS INCSOLE | COM NEW | 77.19K | SH | $802.0K 0.20% | 77.19K | 0.00 | 0.00 |
HERTZ GLOBAL HLDGS INCSOLE | *W EXP 06/30/205 | 16.84K | SH | $92.3K 0.02% | 16.84K | 0.00 | 0.00 |